Entero Healthcare Q1 FY27 Results: Revenue Rs 1,940 Cr, PAT Rs 52 Cr and Key Highlights
- August 12, 2026
- Posted by: Ankit Jaiswal
- Category: News
Entero Healthcare Q1 FY27 results declared August 7, 2026. Revenue Rs 1,940 Cr (+38.23% YoY). PAT Rs 52 Cr (+72.17% YoY). CMP Rs 1242.7 (+0.02%).
Entero Healthcare Q1 FY27 results were declared on August 7, 2026, consolidated. Revenue grew +38.23% YoY to Rs 1,940 Cr from Rs 1,403 Cr in Q1 FY26. The broader BSE Healthcare index reflected mixed sectoral sentiment during the quarter.
Operating profit stood at Rs 84 Cr (+105.54% YoY). PAT came in at Rs 52 Cr (+72.17% YoY), providing a detailed view of Entero Healthcare Q1 FY27 results and business performance.
Click Here – Get Free Investment Predictions
Entero Healthcare Q1 FY27 Financial Highlights
| Metric | Q1 FY27 (Rs Cr) | Q1 FY26 (Rs Cr) | YoY Change |
|---|---|---|---|
| Entero Healthcare Revenue | 1,940 | 1,403 | +38.23% |
| Operating Profit | 84 | 41 | +105.54% |
| Net Profit (PAT) | 52 | 30 | +72.17% |
| Reporting Basis | Consolidated | ||
Entero Healthcare Q1 FY27 Performance Analysis
Check the Univest Screener for Live Data on This Stock
Entero Healthcare Q1 FY27 results reflect strong fundamentals across key financial metrics. The top line showed resilience with revenue reaching Rs 1,940 Cr for the April to June 2026 quarter.
Operating profit expanded +105.54% YoY to Rs 84 Cr. Improving cost absorption and product mix optimisation contributed to the uptick.
PAT of Rs 52 Cr in Entero Healthcare Q1 FY27 results marks a +72.17% YoY movement. Investors monitoring Entero Healthcare Q1 FY27 results will note this as a key milestone for the FY27 earnings trajectory.
Key Business Factors in Entero Healthcare Q1 FY27 Results
Revenue Growth Momentum in the Quarter
Entero Healthcare Q1 FY27 results show top-line expansion of +38.23% YoY to Rs 1,940 Cr. Order book execution and market share gains in the Healthcare Distribution segment supported this trajectory.
Operating Margin Performance
Operating profit in Entero Healthcare Q1 FY27 results improved to Rs 84 Cr (+105.54% YoY). Better product mix, cost discipline, and operating leverage contributed to the improvement.
PAT Trajectory and Profitability Outlook
PAT in Entero Healthcare Q1 FY27 results stood at Rs 52 Cr (+72.17% YoY). The improving PAT trajectory signals strengthening financial health and returns on capital.
Dividend Details
No dividend was declared alongside Entero Healthcare Q1 FY27 results. Earnings are being directed toward operational investments and working capital optimisation.
FY27 Outlook for Entero Healthcare
Entero Healthcare is positioned to sustain growth momentum through FY27 driven by order visibility, sector tailwinds, and operational improvements in the healthcare distribution segment. Management guidance points toward continued focus on margin expansion. Investors tracking Entero Healthcare Q1 FY27 results should consult a SEBI-registered financial advisor before making investment decisions.
Entero Healthcare Stock Performance After Q1 FY27 Results
Download the Univest iOS App or Univest Android App to track Entero Healthcare live price and get daily stock recommendations.
Entero Healthcare shares were trading higher at Rs 1242.7 (+0.02%) on August 7, 2026, reflecting investor sentiment on Entero Healthcare Q1 FY27 results and the near-term sector outlook. The CMP of Rs 1242.7 on the results date reflects broader sentiment in the healthcare distribution space.
Key Risks for Entero Healthcare
Sector-Specific Risks
Credit risk from pharmacy channel and working capital intensity.
Valuation and Earnings Risk
Valuation risk remains if quarterly growth momentum fails to sustain over the next two to three quarters.
Operational and Financial Risk
Subsidiary-level underperformance could drag consolidated PAT lower in subsequent quarters.
Conclusion
Entero Healthcare Q1 FY27 results reflect strong performance with revenue at Rs 1,940 Cr and PAT at Rs 52 Cr on a Consolidated basis. Sector tailwinds and operational discipline will determine the FY27 growth trajectory. Investors should review management commentary and quarterly data before taking any position.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Entero Healthcare Q1 FY27 Results
When were Entero Healthcare Q1 FY27 results declared?
Ans. Entero Healthcare Q1 FY27 results were declared on August 7, 2026, covering the April–June 2026 quarter on a Consolidated basis.
What was Entero Healthcare revenue in Q1 FY27?
Ans. Entero Healthcare Q1 FY27 results show revenue of Rs 1,940 Cr, +38.23% compared to Rs 1,403 Cr in Q1 FY26.
What was Entero Healthcare PAT in Q1 FY27?
Ans. Net profit in Entero Healthcare Q1 FY27 results was Rs 52 Cr, +72.17% year-on-year.
Did Entero Healthcare declare a dividend in Q1 FY27?
Ans. No dividend was announced alongside Entero Healthcare Q1 FY27 results. Check official NSE and BSE announcements for updates.
What is the FY27 outlook for Entero Healthcare?
Ans. Management has guided revenue growth and margin improvement for FY27. Sector trends will remain key monitorables.
How did Entero Healthcare stock react to Q1 FY27 results?
Ans. Entero Healthcare shares were higher at Rs 1242.7 (+0.02%) on August 7, 2026. Consult a SEBI-registered advisor before acting on price movements.
